Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-11-28, Stock:PFE, The news for the past five days is as follows:
2018-11-20: NEWS1: Corcept Initiates Phase III Study for Cushing's Syndrome.NEWS2: Corcept Initiates Phase III Study for Cushing's Syndrome.NEWS3: Corcept Initiates Phase III Study for Cushing's Syndrome.NEWS4: [$$] Diversis Capital Buys Controlling Stake of Tempo.NEWS5: Pfizer Stock Has Risen ~20% in 2018.NEWS6: Pfizer will raise drug prices come January.NEWS7: Health Care Sector Update for 11/20/2018: ORPN, BLRX, BSX, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Health Care Sector Update for 11/20/2018: ORPN, BLRX, BSX, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Pfizer's Bavencio Phase III Study for Ovarian Cancer Fails.NEWS10: Pfizer's Bavencio Phase III Study for Ovarian Cancer Fails.NEWS11: Pfizer's Bavencio Phase III Study for Ovarian Cancer Fails.NEWS12: Pfizer and 3 Other Stock Picks From a 5-Star Growth Fund.NEWS13: Pfizer (PFE) Gains As Market Dips: What You Should Know.NEWS14: Pfizer (PFE) Gains As Market Dips: What You Should Know.NEWS15: 3 Steady Healthcare Stocks to Hold During a Downturn.NEWS16: 3 Steady Healthcare Stocks to Hold During a Downturn.
2018-11-21: NEWS1: FDA approves new blood cancer treatment from Pfizer.NEWS2: Pfizer Stock Has Multiple Positive Catalysts.NEWS3: Pfizer asks GOP Sen. Cindy Hyde-Smith for contribution refund, Facebook alum Sean Parker doesn't.NEWS4: U.S. FDA Approves DAURISMO™ (glasdegib) for Adult Patients with Newly-Diagnosed Acute Myeloid Leukemia (AML) for Whom Intensive Chemotherapy is Not an Option.NEWS5: FDA approves Pfizer's treatment for rare blood cancer.NEWS6: FDA Accepts Allergan's (AGN) sNDA for Anti-Infective Avycaz.NEWS7: FDA Accepts Allergan's (AGN) sNDA for Anti-Infective Avycaz.NEWS8: Dow Movers: JNJ, CAT.NEWS9: Dow Movers: JNJ, CAT.NEWS10: Can Deal Interest Help Tesaro Recover?.NEWS11: Can Deal Interest Help Tesaro Recover?.NEWS12: Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference.NEWS13: Health Care Sector Update for 11/21/2018: SYN, CYAD, JNJ, PFE, ABT, MRK, AMGN.NEWS14: Health Care Sector Update for 11/21/2018: SYN, CYAD, JNJ, PFE, ABT, MRK, AMGN.NEWS15: FDA Accepts Allergan's (AGN) sNDA for Anti-Infective Avycaz.NEWS16: Why Pfizer’s Share Price Fell on November 20.NEWS17: 5 Quality Blue Chips to Thrive in Bull and Bear Markets.NEWS18: [$$] Global markets retreat as tech rout spreads.
2018-11-23: NEWS1: [$$] Pharma Stocks Soothe Stock-Market Malady.NEWS2: These 3 Stocks Are Up 25% in 2018 -- Are They Still Buys?.NEWS3: Pharma Stock Roundup: Cancer Approvals for PFE & ABBV, CHMP Nod for Several Drugs.NEWS4: Pharma Stock Roundup: Cancer Approvals for PFE & ABBV, CHMP Nod for Several Drugs.NEWS5: Dow 30 Stock Roundup: Boeing to Supply 40 737 MAX 8 to Jeju Air, Pfizer Gets FDA Nod.NEWS6: Dow 30 Stock Roundup: Boeing to Supply 40 737 MAX 8 to Jeju Air, Pfizer Gets FDA Nod.NEWS7: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for November 26, 2018.NEWS8: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for November 26, 2018.NEWS9: Pharma Stock Roundup: Cancer Approvals for PFE & ABBV, CHMP Nod for Several Drugs.NEWS10: Dow 30 Stock Roundup: Boeing to Supply 40 737 MAX 8 to Jeju Air, Pfizer Gets FDA Nod.
2018-11-26: NEWS1: Google asks for refund of campaign contribution to embattled Sen. Cindy Hyde-Smith.NEWS2: Spark Therapeutics' Luxturna Gets EU Approval for Vision Loss.NEWS3: Spark Therapeutics' Luxturna Gets EU Approval for Vision Loss.NEWS4: Spark Therapeutics' Luxturna Gets EU Approval for Vision Loss.NEWS5: Interesting January 2020 Stock Options for PFE.NEWS6: Interesting January 2020 Stock Options for PFE.NEWS7: Bayer looks at options for consumer brands, animal health - sources.NEWS8: The Zacks Analyst Blog Highlights: Pfizer, AbbVie, J&J, Glaxo and AstraZeneca.NEWS9: The Zacks Analyst Blog Highlights: Pfizer, AbbVie, J&J, Glaxo and AstraZeneca.NEWS10: ATRS: Xyosted Launch Before Year End.NEWS11: Bayer discusses sale of some consumer brands, future of animal health-sources.NEWS12: The Zacks Analyst Blog Highlights: Pfizer, AbbVie, J&J, Glaxo and AstraZeneca.NEWS13: Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for November 27, 2018.NEWS14: Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for November 27, 2018.
2018-11-27: NEWS1: Close Update: Dow Leads Major Market Gauges Higher as Nasdaq Lags Behind.NEWS2: Close Update: Dow Leads Major Market Gauges Higher as Nasdaq Lags Behind.NEWS3: Pfizer Receives Six Months Pediatric Exclusivity for LYRICA® (pregabalin).NEWS4: Roche buys U.S. biotech Jecure in race for liver disease drugs.NEWS5: Mid-Day Update: Trade Tensions Continue to Plague Wall Street.NEWS6: Mid-Day Update: Trade Tensions Continue to Plague Wall Street.NEWS7: Glaxo (GSK) and J&J's HIV Drug Juluca Gets Approval in Japan.NEWS8: Glaxo (GSK) and J&J's HIV Drug Juluca Gets Approval in Japan.NEWS9: Glaxo (GSK) and J&J's HIV Drug Juluca Gets Approval in Japan.NEWS10: The Zacks Analyst Blog Highlights: Boeing, Microsoft, Johnson & Johnson, Chevron and Pfizer.NEWS11: The Zacks Analyst Blog Highlights: Boeing, Microsoft, Johnson & Johnson, Chevron and Pfizer.NEWS12: 3 Top Biotech Stocks to Buy Right Now.NEWS13: 3 Top Biotech Stocks to Buy Right Now.NEWS14: The Zacks Analyst Blog Highlights: Boeing, Microsoft, Johnson & Johnson, Chevron and Pfizer.

Answer: Rise